Bioduro LLC: Salè H-1B ak pajon
Bioduro LLC depoze 12 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 12. Medyèn salè yo ofri a: $126,400.
Èske Bioduro LLC pajone visa H-1B?
Bioduro LLC depoze 12 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Nov 19, 2024. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Demands Green Card (PERM) pou Bioduro LLC: 3 →
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Director, Business Development - Drug Discovery | 3 | $185,000 |
| Scientist I, Formulation Development | 2 | $94,500 |
| Business Development Director | 1 | $142,800 |
| Scientist III, Formulation Development | 1 | $100,000 |
| Senior Scientist I, Quality Control | 1 | $95,000 |
| Director, Business Development | 1 | $142,800 |
| Senior Associate III, QA | 1 | $110,000 |
| Senior Scientist III, Formulation Development | 1 | $145,000 |
| Sr. Scientist I, Quality Control | 1 | $95,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 8 | $121,400 |
| FY2024 | 2 | $147,500 |
| FY2025 | 2 | $120,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Scientist III, Formulation Development | $145,000 Nivo II | Irvine, CA | Nov 19, 2024 | Dec 9, 2024 | Certifye |
| Sr. Scientist I, Quality Control | $95,000 Nivo II | Irvine, CA | Nov 4, 2024 | May 1, 2025 | Certifye |
| Director, Business Development - Drug Discovery | $185,000 Nivo II | Quincy, MA | May 3, 2024 | May 28, 2024 | Certifye |
| Senior Associate III, QA | $110,000 Nivo II | Irvine, CA | Dec 4, 2023 | Jan 2, 2024 | Certifye |
| Director, Business Development | $142,800 Nivo II | Exton, PA | Jul 19, 2023 | Aug 21, 2023 | Certifye |
| Director, Business Development - Drug Discovery | $185,000 Nivo II | Foster City, CA | Jun 28, 2023 | Jul 12, 2023 | Certifye |
| Director, Business Development - Drug Discovery | $185,000 Nivo II | Santa Clara, CA | Apr 3, 2023 | May 1, 2023 | Certifye |
| Business Development Director | $142,800 Nivo II | Exton, PA | Feb 2, 2023 | Mar 3, 2023 | Certifye |
| Scientist I, Formulation Development | $92,000 Nivo II | Irvine, CA | Jan 27, 2023 | Mar 1, 2023 | Certifye |
| Scientist I, Formulation Development | $97,000 Nivo II | Irvine, CA | Jan 27, 2023 | Mar 1, 2023 | Certifye |
| Scientist III, Formulation Development | $100,000 Nivo II | Irvine, CA | Jan 27, 2023 | Mar 1, 2023 | Certifye |
| Senior Scientist I, Quality Control | $95,000 Nivo II | Irvine, CA | Jan 27, 2023 | Mar 1, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).